WO2009154810A3 - Delivery systems for multiple active agents - Google Patents

Delivery systems for multiple active agents Download PDF

Info

Publication number
WO2009154810A3
WO2009154810A3 PCT/US2009/035100 US2009035100W WO2009154810A3 WO 2009154810 A3 WO2009154810 A3 WO 2009154810A3 US 2009035100 W US2009035100 W US 2009035100W WO 2009154810 A3 WO2009154810 A3 WO 2009154810A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
active agents
multiple active
delivery systems
active agent
Prior art date
Application number
PCT/US2009/035100
Other languages
French (fr)
Other versions
WO2009154810A2 (en
Inventor
Shrikant Vitthalrao Dhoke
Sanjay Shekhranand Tripathi
Deepak Gupta
Nagesh Nagraju
Kb Sankara Rao
Mittapalli Pavan Kumar
Original Assignee
Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc. filed Critical Dr. Reddy's Laboratories Ltd.
Publication of WO2009154810A2 publication Critical patent/WO2009154810A2/en
Publication of WO2009154810A3 publication Critical patent/WO2009154810A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions for the simultaneous delivery of multiple active agents, processes for preparing compositions and methods of using such compositions. The compositions include tablets containing an active agent, contained within a tablet or tablet layer, and optionally contain, or have an external deposit containing, the same or a different active agent. The compositions can deliver chemically incompatible active ingredients having different release profiles, from a single pharmaceutical composition.
PCT/US2009/035100 2008-02-25 2009-02-25 Delivery systems for multiple active agents WO2009154810A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN463/CHE/2008 2008-02-25
IN463CH2008 2008-02-25
US4656608P 2008-04-21 2008-04-21
US61/046,566 2008-04-21

Publications (2)

Publication Number Publication Date
WO2009154810A2 WO2009154810A2 (en) 2009-12-23
WO2009154810A3 true WO2009154810A3 (en) 2010-03-11

Family

ID=41434609

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/035100 WO2009154810A2 (en) 2008-02-25 2009-02-25 Delivery systems for multiple active agents

Country Status (1)

Country Link
WO (1) WO2009154810A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201003731D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
EP2377521A1 (en) 2010-03-26 2011-10-19 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Pharmaceutical formulations of telmisartan and diuretic combination
EP2585051B2 (en) 2010-06-23 2020-04-08 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
ES2587912T3 (en) * 2012-03-30 2016-10-27 Daewoong Pharmaceutical Co., Ltd Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
KR101910901B1 (en) * 2013-11-29 2018-10-24 한미약품 주식회사 Pharmaceutical complex formulation comprising amlodipine, losartan and rosuvastatin
WO2016004960A2 (en) * 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet
SI2965750T1 (en) * 2014-07-11 2017-11-30 Azanta Danmark A/S Misoprostol dispersible tablet
US20160008310A1 (en) 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet
CN104324037B (en) * 2014-11-12 2016-06-08 常州市第四制药厂有限公司 A kind of tablet containing valsartan and hydrochlorothiazide and preparation method thereof
KR20170003459A (en) * 2015-06-30 2017-01-09 한미약품 주식회사 Pharmaceutical complex formulation comprising amlodipine, losartan and rosuvastatin
CN110755429A (en) * 2018-07-26 2020-02-07 北京市石景山区高血压联盟研究所 Compound antihypertensive medicine composition, preparation and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033448A1 (en) * 1997-12-23 1999-07-08 Merck Patent Gmbh Tablet for instant and prolonged release of one or more active substances
WO2003026629A2 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Modified release dosage forms
WO2006010394A2 (en) * 2004-07-23 2006-02-02 Röhm Gmbh Medicament in a multilayer form

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033448A1 (en) * 1997-12-23 1999-07-08 Merck Patent Gmbh Tablet for instant and prolonged release of one or more active substances
WO2003026629A2 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Modified release dosage forms
WO2006010394A2 (en) * 2004-07-23 2006-02-02 Röhm Gmbh Medicament in a multilayer form

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STREUBEL, A. ET AL.: "Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design", JOURNAL OF CONTROLLED RELEASE, vol. 69, 2000, pages 455 - 468 *

Also Published As

Publication number Publication date
WO2009154810A2 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
WO2009154810A3 (en) Delivery systems for multiple active agents
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
WO2007127363A3 (en) Coatings containing multiple drugs
HK1219023A1 (en) Plant support formulation, vehicle for the delivery and translocation of phytologically beneficial substances and compositions containing same
WO2010048478A3 (en) Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates
WO2007016388A3 (en) Liquid formulations for controlled delivery of benzisoxazole derivatives
BRPI0606883A2 (en) pharmaceutical composition for oral administration, method for preparing a tablet, and single solid dosage form
WO2007133583A3 (en) Zero-order modified release solid dosage forms
WO2008042748A3 (en) Polyelectrolyte media for bioactive agent delivery
WO2006084164A8 (en) Gastric retention and controlled release delivery system
WO2008132712A3 (en) Combination pharmaceutical compositions
IL186162A (en) Aerosolized medicament containing amikacin and systems and devices for delivering the same
WO2006101815A3 (en) Pharmaceutical compositions comprising polyoxaester and active agents for use with osmotic delivery systems
WO2009059701A3 (en) Sustained release tablets with hydromorphone
WO2008157372A3 (en) Self assembled films for protein and drug delivery applications
HK1172845A1 (en) Novel pharmaceutical formulations against drug misuse
WO2007085629A3 (en) Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents
WO2012158030A3 (en) Drug delivery system
GB0715493D0 (en) Delivery systems for solubilising water-insoluble pharmaceutical active ingredients
WO2012172433A3 (en) A sustained -release composition containing a melanocortin receptor ligand as the active ingredient
WO2004062552A3 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
MX2009004960A (en) Sugar coatings and methods therefor.
WO2007079391A3 (en) Drug delivery system for bioadhesion to a vulvovaginal surface
WO2008070354A3 (en) 5- and 6- substituted benzimidazole thiophene compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09767123

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09767123

Country of ref document: EP

Kind code of ref document: A2